Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2009 | 2010 | 2011 | 2012 | 2013 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $114.4K | $184.5K | $590.1K | $479.5K | $2.4M | $1.5M | $3.5M | $9.2M |
| Cost of revenue | $802 | $0 | $0 | $0 | $1.3M | $349.2K | $2.6M | $2.5M |
| Gross profit | $113.6K | $0 | $0 | $0 | $1.2M | $1.2M | $928.5K | $6.8M |
| Gross margin | 99.3% | 0.0% | 0.0% | 0.0% | 48.0% | 77.3% | 26.3% | 73.4% |
| R&D | $2.6K | $0 | $0 | $0 | $36.1K | $0 | $0 | $0 |
| Operating income | −$20.6K | −$474.0K | −$308.0K | −$427.0K | −$1.4M | −$4.7M | −$3.0M | −$2.7M |
| EBITDA | −$19.7K | $0 | $0 | $0 | −$1.4M | $0 | $0 | −$2.7M |
| Net income | −$23.3K | $857.3K | −$480.0K | $311.4K | −$1.6M | −$4.7M | −$3.0M | −$2.8M |
| Net margin | -20.3% | 464.7% | -81.3% | 64.9% | -68.4% | -308.5% | -86.0% | -30.1% |
| EPS (diluted) | -11.50 | 0.00 | 0.00 | 0.00 | -1.06 | -54.60 | -0.03 | -0.49 |
Annual figures · source: Financial Modeling Prep
HEALTHCARE SOLUTIONS MGMT
No one on the platform currently holds HSMD.
No tracked institution reports a position in HSMD as of their last filing.
No one on the platform has traded HSMD yet.
| +0.00% |
| $1815 |
| — |
| MDITMedite Cancer Diagnostics, Inc. | $0.00 | +0.00% | $8672 | — |
| MDXLMedixall Group, Inc. | $0.01 | +0.00% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.